Biofore COVID19 testing reagents and equipment
Ended Awarded Last action
- Contract number
- 36C24124N0723
- Awardee
-
Biofire Diagnostics LLC UEI TBBNREFT3LD3
- Awarding agency
-
Veterans Integrated Service Network 1
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,517,148
Award facts
- Contract value 100% obligated
- $1,517,147.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Emigration Canyon, UT 84108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$151,252 | |
| Other Administrative Action | $200,000 | |
| Original award | $1,468,400 |
About this award
Biofire Diagnostics LLC was awarded a $1.52 million firm fixed-price Blanket Purchase Agreement (BPA) call by the Department of Veterans Affairs' Veterans Integrated Service Network 1 on August 19, 2024, for COVID-19 testing reagents and equipment. The contract carries an ultimate completion date of August 18, 2025, and will be performed at the company's facility in Emigration Canyon, Utah. This award was issued without a set-aside designation, reflecting Biofire's competitive positioning in the federal marketplace. The contract is associated with the company's General Services Administration Federal Supply Schedule contract for In-Vitro Diagnostics, Reagents, and Tests (FSS-65-VII), under which the VA and other federal healthcare agencies procure diagnostic products on an as-needed basis.
Biofire Diagnostics is a Salt Lake City-based biotechnology company specializing in advanced molecular diagnostic testing solutions, with particular expertise in rapid pathogen detection through its FilmArray platform and related reagent products. The company maintains an extensive federal contract portfolio focused on the Department of Veterans Affairs, supporting critical healthcare diagnostic capabilities across multiple Veterans Integrated Service Networks. This BPA call represents part of Biofire's ongoing strategic engagement with federal healthcare systems to supply essential diagnostic testing capabilities, consistent with its track record of delivering specialized infectious disease detection products to VA facilities and other federal health agencies.
Quick answers
Who was awarded contract 36C24124N0723?
36C24124N0723 was awarded to Biofire Diagnostics LLC by Veterans Integrated Service Network 1 (Veterans Health Administration) on August 19, 2024.
How much is contract 36C24124N0723 worth?
The government has obligated $1,517,148 on 36C24124N0723.
Is contract 36C24124N0723 an order under another contract?
Yes. 36C24124N0723 is a BPA call under V797D30085-36C24121A0048, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C24124N0723 competed?
The extent of competition for 36C24124N0723 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award